6,14-Ethenomorphinan-7-methanol, 3,3'-[1,2-ethanediylbis(oxy)]bis[17-(cyclopropylmethyl)-α-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-6-methoxy-α-methyl-, (αS,5α,7α)-(α'S,5'α,7'α)-

6,14-Ethenomorphinan-7-methanol, 3,3'-[1,2-ethanediylbis(oxy)]bis[17-(cyclopropylmethyl)-α-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-6-methoxy-α-methyl-, (αS,5α,7α)-(α'S,5'α,7'α)- 구조식 이미지
카스 번호:
1820753-68-1
상품명:
6,14-Ethenomorphinan-7-methanol, 3,3'-[1,2-ethanediylbis(oxy)]bis[17-(cyclopropylmethyl)-α-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-6-methoxy-α-methyl-, (αS,5α,7α)-(α'S,5'α,7'α)-
동의어(영문):
ORP-101;6,14-Ethenomorphinan-7-methanol, 3,3'-[1,2-ethanediylbis(oxy)]bis[17-(cyclopropylmethyl)-α-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-6-methoxy-α-methyl-, (αS,5α,7α)-(α'S,5'α,7'α)-
CBNumber:
CB39808105
분자식:
C60H84N2O8
포뮬러 무게:
961.34
MOL 파일:
1820753-68-1.mol

6,14-Ethenomorphinan-7-methanol, 3,3'-[1,2-ethanediylbis(oxy)]bis[17-(cyclopropylmethyl)-α-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-6-methoxy-α-methyl-, (αS,5α,7α)-(α'S,5'α,7'α)- 속성

밀도
1.28±0.1 g/cm3(Predicted)
산도 계수 (pKa)
14.69±0.29(Predicted)

안전

6,14-Ethenomorphinan-7-methanol, 3,3'-[1,2-ethanediylbis(oxy)]bis[17-(cyclopropylmethyl)-α-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-6-methoxy-α-methyl-, (αS,5α,7α)-(α'S,5'α,7'α)- C화학적 특성, 용도, 생산

6,14-Ethenomorphinan-7-methanol, 3,3'-[1,2-ethanediylbis(oxy)]bis[17-(cyclopropylmethyl)-α-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-6-methoxy-α-methyl-, (αS,5α,7α)-(α'S,5'α,7'α)- 준비 용품 및 원자재

원자재

준비 용품


6,14-Ethenomorphinan-7-methanol, 3,3'-[1,2-ethanediylbis(oxy)]bis[17-(cyclopropylmethyl)-α-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-6-methoxy-α-methyl-, (αS,5α,7α)-(α'S,5'α,7'α)- 공급 업체

글로벌( 3)공급 업체
공급자 전화 이메일 국가 제품 수 이점
ShangHai Caerulum Pharma Discovery Co., Ltd. 18149758185
sales-cpd@caerulumpharma.com China 3466 58
Nantong QuanYi Biotechnology Co., Ltd 0513-66337626 18051384581
sales@chemhifuture.com China 4679 58
TargetMol Chemicals Inc. 15002134094
marketing@targetmol.cn China 19696 58

Copyright 2019 © ChemicalBook. All rights reserved